Staphylococcus Aureus in Lower Respiratory Infections: Clinical Relevance of Antimicrobial Resistance

Semin Respir Infect. 2001 Sep;16(3):196-202. doi: 10.1053/srin.2001.25625.

Abstract

Staphylococcus aureus is the most common cause of nosocomial infections and is responsible for many community-acquired infections. Of concern is the increase in resistance to oxacillin (methicillin), with rates as high as 60% in some countries and in some intensive care units. Most of these strains are resistant to other antibacterials. Lately, strains with reduced susceptibility to glycopeptides have been reported.

Publication types

  • Review

MeSH terms

  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / microbiology*
  • Cross Infection / drug therapy
  • Cross Infection / microbiology*
  • Humans
  • Lung Diseases / drug therapy
  • Lung Diseases / microbiology*
  • Microbial Sensitivity Tests
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology*
  • Staphylococcus aureus / drug effects*